A pharma packaging company Bilcare Research of Pune has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and fingerprinting.
Private equity firms have reportedly shown interest picking up stake in Bengal Faith Health Care, the Special Purpose Vehicle (SPV) formed to set up the Bardhaman Health City, a INR 1,000 crore PPP (public-private partnership project) to come up on a 60-acre plot near Durgapur Expressway(NH-42).
In a year’s time, cancer treatment will become a matter of a few hours. Top private hospitals are pumping in INR 200 crore to augment cancer detection and treatment facility in Kolkata.
India would launch a satellite in June next year to provide computer connectivity in remote villages, a Space Department official has said.
The Bangalore-based firm has finally received some recognition with the World Economic Forum (WEF) choosing it as one of the 39 technology pioneers from a list of 273 nominees. Neurosynaptics, the only company from India in a list dominated by 23 US firms, has been picked for its ReMeDi (Remote Medical Diagnostics) range of products.
Fortis Healthcare is considered to have one of the best IT infrastructure among healthcare providers in India and is proud of being the pioneer in deploying Web-based HIS system.
Red Hat Software Services, provider of Linux and open source technologies, is making its way into the Indian healthcare sector.
Perot Systems Corporation today announced that the company has been selected by the American Academy of Professional Coders (AAPC) to represent AAPC in South India, including Chennai, Bangalore, and Hyderabad.
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia, particularly in India and China.
IBM is targeting multi-billion dollar health business opportunities in India. The company has plans to tap opportunities worth $1 billion each in the Indian pharmaceuticals and health service segments over the next 3-4 years.
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
